Mitsubishi UFJ Morgan Stanley Securities’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20
Closed -$1K 100
2022
Q4
$1K Sell
20
-30
-60% -$2.14K 0.01% 192
2022
Q3
$3K Hold
50
0.04% 157
2022
Q2
$3K Hold
50
﹤0.01% 160
2022
Q1
$4K Sell
50
-180
-78% -$12.9K ﹤0.01% 157
2021
Q4
$18K Buy
+230
New +$16.9K 0.01% 130

Other funds holding HOLX

Mitsubishi UFJ Morgan Stanley Securities's HOLX Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Hologic (HOLX) in Q1 2023, closing a stake of 20 shares — an estimated $1K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in HOLX in Q4 2021 and held it in 5 quarters. The position peaked at $18K in Q4 2021. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 20 Hologic shares in Q1 2023, an estimated $1K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Hologic in Q4 2021 and held it in 5 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Hologic position peaked at $18K in Q4 2021.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.